4
this type of analysis in the health economics literature. 4 The concentration curve plots the cumulative share of the 5 population ranked by living standards (proxied by GDP per capita in our analysis), against the cumulative share 36 37 
47
The inequalities observed through the concentration curves and indices described above must not be directly 48 interpreted as inequity. Variation in disbursements due to differences in healthcare need is a legitimate source of 49 inequality. Those countries with greater burden of disease legitimately ought to be entitled to higher disbursements 50 compared to those with a lower disease burden. Therefore, to determine the extent of inequity a comparison needs 51 to be made between the distributions of need (malaria burden) and expenditure in malaria across income deciles. 
64
In particular, if the need curve lies above (below) the funding curve then there is horizontal inequity favoring the 65 better-off (worse-off) with the higher income countries obtaining a higher (lower) share of funding than their share 66 of need, and then will result in an unequal pro-rich (pro-poor) distribution of malaria funding across countries.
68
Vertical Equity of Malaria funding
69
We also assess vertical inequity, i.e. the extent to which countries with unequal ability to finance malaria control 70 and elimination receive appropriately unequal funding from international donors. More specifically, the concept 71 of vertical equity helps to identify whether a particular source of funding is 'progressive' (i.e. . We used the decision rule "intersection union principle" that has been theoretically presented and 98 empirically used to infer statistically significant differences between concentration curves. This rule requires 99 statistically significant difference between ordinates at all quantile points in order to assign dominance and 100 reduces the probability of erroneously rejecting non-dominance at the cost of reducing the power of detecting 101 dominance when true 2 .
